You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 12, December 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Men's Health
 •Men's Health, Other
 •Neurology
 •Cognitive Disorders
 •Psychopharmacology
 •Schizophrenia
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Startle Gating Deficits in a Large Cohort of Patients With Schizophrenia

Relationship to Medications, Symptoms, Neurocognition, and Level of Function

Neal R. Swerdlow, MD, PhD; Gregory A. Light, PhD; Kristin S. Cadenhead, MD; Joyce Sprock, BA; Ming H. Hsieh, MD; David L. Braff, MD

Arch Gen Psychiatry. 2006;63:1325-1335.

Context  Patients with schizophrenia exhibit deficits in automatic, preattentive sensorimotor gating (prepulse inhibition [PPI]) of the startle reflex.

Objective  To assess the relationships between PPI deficits and demographic, clinical, neurocognitive, and functional status in a large cohort of patients with schizophrenia.

Design  Cross-sectional comparison of patients with schizophrenia and normal comparison subjects.

Setting  University-based psychophysiology laboratory.

Participants  Carefully screened patients with schizophrenia (n = 103) and normal comparison subjects (n = 66).

Main Outcome Measures  Participants were assessed in structured clinical interviews and tested in measures of acoustic startle PPI and neurocognition. The level of functioning was assessed in patients using validated scales. Analyses first compared all of the patients vs normal comparison subjects. Patients were then divided based on sex, medications, smoking status, and levels of PPI. The associations of PPI to clinical, neurocognitive, and functional variables were assessed using both continuous and categorical analyses.

Results  Compared with normal comparison subjects, patients exhibited PPI deficits at 60-millisecond intervals but not at 30- or 120-millisecond intervals. In addition, patients exhibited deficits in neurocognition. Among patients, PPI levels were associated with sex (higher in men than in women), medication status (highest in patients treated with atypical antipsychotics), and smoking (higher in smokers than in nonsmokers). Compared with patients in the highest quartile of PPI, those in the lowest quartile of PPI were significantly more impaired on specific functional measures but did not differ in neurocognitive measures or symptom severity. The relationship between low PPI and functional impairment was most pronounced and orderly in male patients.

Conclusions  These findings highlight several important factors (sex, medications, and smoking status) that strongly impact the study and interpretation of PPI deficits in patient populations. These results also support the concept that deficient PPI is associated with impaired functional status in schizophrenia.


Author Affiliations: Departments of Psychiatry, University of California, San Diego, School of Medicine, La Jolla (Drs Swerdlow, Light, Cadenhead, and Braff and Ms Sprock), and National Taiwan University Hospital, Taipei, Taiwan (Dr Hsieh).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Precedence-effect-induced enhancement of prepulse inhibition in socially reared but not isolation-reared rats
Du et al.
Cogn Affect Behav Neurosci 2009;9:44-58.
ABSTRACT  

Impaired Prepulse Inhibition and Prepulse-Elicited Reactivity but Intact Reflex Circuit Excitability in Unmedicated Schizophrenia Patients: a Comparison With Healthy Subjects and Medicated Schizophrenia Patients
Csomor et al.
Schizophr Bull 2009;35:244-255.
ABSTRACT | FULL TEXT  

S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects
Millan et al.
J. Pharmacol. Exp. Ther. 2008;324:1212-1226.
ABSTRACT | FULL TEXT  

Initial Heritability Analyses of Endophenotypic Measures for Schizophrenia: The Consortium on the Genetics of Schizophrenia
Greenwood et al.
Arch Gen Psychiatry 2007;64:1242-1250.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.